# Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

Study · id `cardio:ct-nct03951207` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03951207](<https://clinicaltrials.gov/study/NCT03951207>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03951207

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; High blood pressure; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.

## Technical summary

Registry record NCT03951207. Randomized; no masking; primary purpose treatment. Start 2019-05-30 (actual); primary completion 2021-09-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 259 participants (enrolled count; ClinicalTrials.gov record NCT03951207, source copy `cardio:ctgov-nct03951207-2022-10-12`, retrieved 2026-10-26)
- Started: 2019-05-30 (actual) (ClinicalTrials.gov record NCT03951207, source copy `cardio:ctgov-nct03951207-2022-10-12`, retrieved 2026-10-26)
- Primary completion: 2021-09-29 (actual) (ClinicalTrials.gov record NCT03951207, source copy `cardio:ctgov-nct03951207-2022-10-12`, retrieved 2026-10-26)
- Completion: 2021-09-29 (actual) (ClinicalTrials.gov record NCT03951207, source copy `cardio:ctgov-nct03951207-2022-10-12`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03951207, source copy `cardio:ctgov-nct03951207-2022-10-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03951207-2022-10-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
- Acronym: CORONA
- Condition: Dyslipidemias
- Condition: Hypertension
- Intervention (Drug): Rosuampin 10/5mg
- Intervention (Drug): Rosuampin 20/5mg
- Intervention (Drug): Amlodipine/Atorvastatin 5/20mg
- Lead sponsor: Yuhan Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Yuhan Corporation (`cardio:org-yuhan-corporation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia (`cardio:pubmed-37584254`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9ec9df8a967095861cbc9209babdc8f83b2e2ed551d50f25d4e755aede143dc5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
